ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2943

Ultrasound Scoring of One Parotid and One Submandibular Gland in Primary Sjogren’s Syndrome – Further Increasing Feasibility in Outpatient Clinics

Esther Mossel1, Suzanne Arends2, Jolien F. van Nimwegen2, Konstantina Delli3, Alja J. Stel1, Frans G.M. Kroese2, Fred K.L. Spijkervet4, Arjan Vissink5 and Hendrika Bootsma2, 1Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, the Netherlands, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 3Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands, Groningen, Netherlands, 4Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Department of Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Sjogren's syndrome and ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 8, 2017

Title: Imaging of Rheumatic Diseases II: Focus on Rheumatoid Arthritis and Systemic Sclerosis

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose:

To assess whether ultrasonographic scoring of (i) both parotid and submandibular salivary glands and (ii) all components of the Hocevar scoring system1, is needed for classifying patients as primary Sjögren’s syndrome (pSS).

Methods:

Ultrasound examination of the major salivary glands (sUS) was performed in 204 consecutive outpatients, diagnosed or clinically suspected with pSS.

Parenchymal echogenicity, homogeneity, hypoechogenic areas, hyperechogenic reflections and salivary gland posterior border were scored in the right and left parotid and submandibular glands1. Univariate and multivariate logistic regression analyses were performed to assess which salivary glands and sUS components significantly predicted classification as pSS or non-pSS according to the 2016 ACR-EULAR criteria2.

Results:

116 (57%) patients were classified as pSS, the remaining 88 (43%) patients as non-pSS. The correlation between the sUS scores of both parotid glands (ρ=0.909), both submandibular glands (ρ=0.868) and between the left and right glands (ρ=0.926) was excellent. The correlation between the sUS scores of the left parotid and left submandibular gland (ρ=0.731) and between the right parotid and right submandibular gland (ρ=0.734) was slightly lower.

Multivariate analysis showed that sUS scores of one parotid gland and one submandibular gland contributed independently to ACR-EULAR classification. Instead of scoring both sides (area under the curve, AUC=0.856; Nagelkerke R2=0.527), sUS scoring of only the right (AUC=0.850; R2=0.518) or left (AUC=0.852; R2=0.511) parotid and submandibular glands is enough to significantly predict classification of patients according to the ACR-EULAR criteria.

In univariate analysis, all individual components of the Hocevar scoring system significantly predicted ACR-EULAR classification. Hypoechogenic areas showed the highest explained variance (R2=0.508). Multivariate analysis showed that only parenchymal echogenicity and hypoechogenic areas independently predicted ACR-EULAR classification (AUC=0.857; R2=0.539). Taking only the sUS scores of the right glands into account, multivariate analysis showed that only parenchymal echogenicity and hypoechogenic areas contributed independently to ACR-EULAR classification (AUC=0.855; R2=0.539). However, when scoring only hypoechogenic areas on one side, results were comparable (AUC=0.846; R2=0.498). Similar results were found when the analyses were repeated for the left glands.

Conclusion:

sUS examination of a parotid and submandibular gland on one side is enough to predict classification of patients according to the ACR-EULAR criteria.

Presence of hypoechogenic areas is the best predictor of ACR-EULAR classification. Although parenchymal echogenicity also independently predicted ACR-EULAR classification, its reliability is limited.3 Therefore, we conclude that sUS scoring of only hypoechogenic areas in one parotid and submandibular gland is enough to predict ACR-EULAR classification. These finding may increase the feasibility of sUS in outpatients clinics worldwide.

References:

1 Hocevar et al. Rheumatology 2005.

2 Shiboski et al. Ann Rheum Dis 2017.

3 Delli et al. Ultraschall Med 2017.


Disclosure: E. Mossel, None; S. Arends, None; J. F. van Nimwegen, None; K. Delli, None; A. J. Stel, None; F. G. M. Kroese, None; F. K. L. Spijkervet, None; A. Vissink, None; H. Bootsma, None.

To cite this abstract in AMA style:

Mossel E, Arends S, van Nimwegen JF, Delli K, Stel AJ, Kroese FGM, Spijkervet FKL, Vissink A, Bootsma H. Ultrasound Scoring of One Parotid and One Submandibular Gland in Primary Sjogren’s Syndrome – Further Increasing Feasibility in Outpatient Clinics [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/ultrasound-scoring-of-one-parotid-and-one-submandibular-gland-in-primary-sjogrens-syndrome-further-increasing-feasibility-in-outpatient-clinics/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-scoring-of-one-parotid-and-one-submandibular-gland-in-primary-sjogrens-syndrome-further-increasing-feasibility-in-outpatient-clinics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology